Kolexia
Melon-David Valerie
Pédiatrie
Hôpital Hôtel-Dieu Nantes
Nantes, France
32 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mucoviscidose Fibrose Hypersensibilité Maladie chronique Hypersensibilité alimentaire Dermatite Aspergillose Maladies pulmonaires Infections à Pseudomonas

Industries

Vertex
1 collaboration(s)
Dernière en 2016
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Experiences Among Patients With Cystic Fibrosis in the MucoExocet Study of Using Connected Devices for the Management of Pulmonary Exacerbations: Grounded Theory Qualitative Research.
JMIR formative research   23 janvier 2024
MucoExocet: Use of Home-based Connected Devices to Early Detect and Treat Pulmonary Exacerbations: Feasibility and Clinical Validity in CF Patients
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   09 juin 2022
Use of Home-Based Connected Devices in Patients With Cystic Fibrosis for the Early Detection and Treatment of Pulmonary Exacerbations: Protocol for a Qualitative Study.
JMIR research protocols   18 août 2021
Consensus Recommendations for the Use of Simulation in Therapeutic Patient Education.
Simulation in healthcare : journal of the Society for Simulation in Healthcare   21 décembre 2020
One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance.
The Journal of antimicrobial chemotherapy   05 août 2020
Provision of information on transplantation to cystic fibrosis patients and their relatives: Overview of French practices and recommendations.
Respiratory medicine and research   23 janvier 2020
Quality criteria for the transition to adult care in French CF centers - results from the SAFETIM APP study?.
Revue des maladies respiratoires   14 juin 2019
Prise en charge des bactéries rares présentes dans les ECBC de patients atteints de mucoviscidose non greffés
20es Journées Nationales d’Infectiologie - 5-7 juin 2019 - Centre des Congrès de Lyon   01 juin 2019
MUCO-ART-PLUS: Perceived Impact of Art Therapy in Patients With Cystic Fibrosis (Adolescents, Adults and Transplanted Not Transplanted) and in Professional Interdisciplinary Teams Taking Care of Them.
Essai Clinique (CHU Nantes)   29 janvier 2019
MUCO-ART: Impact of Art Therapy on Anxiety Identified During the Quarterly Update of Hospitalizations Among Children With Cystic Fibrosis Aged 8 to 13 - Pilot Study
Essai Clinique (CHU Nantes)   29 janvier 2019